Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Toshirou Kawano"'
Autor:
Junichi Ishitoya, Toshirou Kawano, Masanori Komatsu, Mamoru Tsukuda, Youichi Ikeda, Osamu Shiono
Publikováno v:
Nihon Kikan Shokudoka Gakkai Kaiho. 61:8-14
化学放射線同時併用療法の晩期有害事象が摂食・嚥下に与える影響について検討した。頭頸部癌進行例で化学放射線療法を行った患者のうち，組織学的CRが得られた後，1年以上経過した
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dbb460ec5894dfcafeeff581a404dc1
https://doi.org/10.2468/jbes.61.8
https://doi.org/10.2468/jbes.61.8
Autor:
Junichi Ishitoya, Toshirou Kawano, Mamoru Tsukuda, Masanori Komatsu, Youichi Ikeda, Ryo Ikoma
Publikováno v:
Practica Oto-Rhino-Laryngologica. 103:533-540
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::649f5f98c70d84efd2b6fa034933a8b3
https://doi.org/10.5631/jibirin.103.533
https://doi.org/10.5631/jibirin.103.533
Autor:
Mamoru Tsukuda, Madoka Furukawa, Toshiyuki Kokatu, Yoshiyasu Nakamura, Toshirou Kawano, Shunsuke Yanoma, Osamu Shiono, Akira Kubota
Publikováno v:
American Journal of Otolaryngology. 26:308-313
Purpose Standard CD44 (CD44st), CD44 variant 5 (CD44v5), and CD44 variant 6 (CD44v6), intercellular adhesion molecule 1(ICAM-1), and vascular cell adhesion molecule 1(VCAM-1) are expressed in human malignant cells and tissues. Their mechanism remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c3ff63a5b7297b22295a72546fbf7f
https://doi.org/10.1016/j.amjoto.2005.02.005
https://doi.org/10.1016/j.amjoto.2005.02.005
Autor:
Akemi Ozeki, Akira Kubota, Madoka Furukawa, Toshirou Kawano, Toshiyuki Kokatsu, Shunsuke Yanoma, Yoshiyasu Nakamura, Mamoru Tsukuda
Publikováno v:
Acta Oto-Laryngologica. 125:392-397
The possible roles of CD44st, CD44v5 and CD44v6 in the prognosis of head and neck cancer deserve further elucidation and evaluation with long-term patient follow-up.Standard CD44 (CD44st), CD44 variant 5 (CD44v5) and CD44 variant 6 (CD44v6) are expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe194a2631e735576bc5f00babd33a0b
https://doi.org/10.1080/00016480510026971
https://doi.org/10.1080/00016480510026971
Publikováno v:
Japanese jornal of Head and Neck Cancer. 30:39-46
放射線根治治療を選択した進行喉頭・下咽頭癌症例について検討した。1986年から2002年までに根治治療として放射線治療を選択したStage III・IVの喉頭・下咽頭癌症例120例 (Stage III25例・IV95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e2a5febf575e0333a5f73a67bcc0a0f
https://doi.org/10.5981/jjhnc1974.30.39
https://doi.org/10.5981/jjhnc1974.30.39
Publikováno v:
Nihon Kikan Shokudoka Gakkai Kaiho. 52:325-330
当科では1994年以降のインフォームド・コンセントの徹底以来，根治治療に放射線治療を選択する下咽頭癌患者が増加した。そこで1986年9月から1999年12月までに治療した重複癌および遠隔
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27450a752ba0da97815053e6d5ec131e
https://doi.org/10.2468/jbes.52.325
https://doi.org/10.2468/jbes.52.325
Publikováno v:
The Journal of Laryngology & Otology. 115
The anti-tumour effect of the angiogenic inhibitor TNP470, sigma-(chloro-acetyl-carbamoyl) fumagillol, a synthetic analogue of fumagillin, was studied in vitro and in vivo using KB cells, one of the human head and neck carcinoma cell lines that produ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8d7d24936b65fe40ea7a9f556af51b
https://doi.org/10.1258/0022215011909305
https://doi.org/10.1258/0022215011909305